4th Circ. Revives Antitrust Suit Over Actelion's Drug Tracleer
The Fourth Circuit on Tuesday revived Baltimore's antitrust suit accusing Actelion Pharmaceuticals of illegally pumping up the price of its drug Tracleer after the patent expired, reversing a decision that the case was...To view the full article, register now.
Already a subscriber? Click here to view full article